CTOs on the Move

Florida's Blood Center

www.floridasbloodcenters.org

 
Founded in 1942 FBC is now the sole supplier of blood products to 70 healthcare facilities in a 22-country area. Annually, more than 350000 pints of blood are collected from volunteers. FBC is the fourth largest independent blood bank in the nation.
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Oxy Health Corp

Oxy Health Corp is a Santa Fe Springs, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Well

American Well transforms healthcare delivery through telehealth. We make online doctor visits accessible to everyone for one-off care issues like colds or infections, and chronic condition management, such as diabetes or depression. We deliver healthcare into people`s homes and workplaces through our work with top health plans, health systems and employers, as well as our telehealth app, Amwell. A patient using Amwell can connect to a board-certified doctor of their choosing in just minutes for a visit carried out over smartphone, tablet, kiosk, phone, or desktop.

Plexus Learning Designs

Plexus Learning Designs is a Marblehead, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Bailey Health Group

The Bailey Group is the largest pure employee benefits firm in Northeast Florida with over 70 full-time representatives, each dedicated to being an extension of their clients` HR departments.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.